Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy

PHASE4UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 2, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

June 30, 2022

Conditions
Arrhythmias, CardiacAtrial Fibrillation
Interventions
DRUG

Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients with Atrial Fibrillation

The hypothesis to be tested is that the intravenous loading regimen followed by oral sotalol administration 4 hours after the conclusion of the IV infusion (every 12 hours thereafter) will result in sotalol peak concentrations at the end of IV loading dose (IV to oral loading) which are comparable to the steady state and maximum QTc seen on Day 3 after the last in-hospital oral dose.

Trial Locations (1)

66211

RECRUITING

Kansas City Heart Rhythm Institute, Overland Park

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Texas Cardiac Arrhythmia Research Foundation

OTHER

collaborator

Munson Medical Center

OTHER

lead

Kansas City Heart Rhythm Research Foundation

OTHER

NCT04473807 - Feasibility and Safety of IV Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy | Biotech Hunter | Biotech Hunter